The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I,
##STR1##
wherein the substituents are as defined in the specification, as well as
their use as pharmaceuticals.
The compounds of the invention are particularly suited for treating neurological
disorders such as epilepsy.